Specialty Care

How Will AI and Portability Reshape Global Ultrasound?
Care Providers How Will AI and Portability Reshape Global Ultrasound?

Medical imaging is no longer confined to the cold, sterile basements of large metropolitan hospitals where heavy, expensive machines remained tethered to specific rooms. The global ultrasound diagnostic equipment market is currently witnessing a paradigm shift, as the technology transforms from a

2024 McDonald Criteria Mandate Protocol Audits for MS Trials
Clinical & Pharma 2024 McDonald Criteria Mandate Protocol Audits for MS Trials

The landscape of neurological research underwent a fundamental transformation with the publication of the 2024 McDonald Criteria in The Lancet Neurology, setting a new benchmark for diagnostic accuracy and speed. These updated standards replaced the long-standing 2017 framework, introducing a more

How Did Richard Scolyer’s Final Act Change Cancer Research?
Clinical & Pharma How Did Richard Scolyer’s Final Act Change Cancer Research?

The diagnosis of an aggressive glioblastoma in one of the world's leading pathological experts created an unprecedented opportunity to challenge established medical boundaries through self-experimentation. Professor Richard Scolyer, recognized globally for his pioneering work in melanoma, turned

Can 4K HDR Technology Improve Remote Clinical Diagnosis?
Tech & Innovation Can 4K HDR Technology Improve Remote Clinical Diagnosis?

The rapid evolution of decentralized healthcare has fundamentally altered the patient experience, yet a significant technological bottleneck persists when standard-definition webcams fail to provide the granular detail necessary for complex medical assessments. While the transition toward virtual

Non-Invasive Ultrasound Successfully Treats Rare Twin Condition
Clinical & Pharma Non-Invasive Ultrasound Successfully Treats Rare Twin Condition

The delicate balance of life within the womb has long been one of the most challenging frontiers for modern medicine, where every intervention must be weighed against the extreme vulnerability of a developing fetus. For decades, clinicians have grappled with the terrifying reality of Twin-Twin

Axxam and HeartBeat.bio Partner for Cardiac Drug Discovery
Tech & Innovation Axxam and HeartBeat.bio Partner for Cardiac Drug Discovery

The pharmaceutical industry has long grappled with a persistent and costly bottleneck in the development of life-saving medications: the inability of animal models to accurately predict human responses. On July 9, 2026, Axxam S.p.A. and HeartBeat.bio AG announced a landmark strategic partnership

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later